The global Natamycin market is projected to grow from US$ 198.9 million in 2024 to US$ 288.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Natamycin Market

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

Report Covers:

This report presents an overview of global market for Natamycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Natamycin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Natamycin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Natamycin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Natamycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Natamycin sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Natamycin Market Report

Report Metric	Details
Report Name	Natamycin Market
Accounted market size in 2024	US$ 198.9 million
Forecasted market size in 2030	US$ 288.6 million
CAGR	6.4
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Glucose-based Lactose-based Sodium chloride-based
Segment by Application	Food Medical Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Natamycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natamycin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Natamycin Market growing?

Ans: The Natamycin Market witnessing a CAGR of 6.4 during the forecast period 2024-2030.

What is the Natamycin Market size in 2030?

Ans: The Natamycin Market size in 2030 will be US$ 288.6 million.

What is the market share of major companies in Natamycin Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Natamycin Market report?

Ans: The main players in the Natamycin Market are VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome

What are the Application segmentation covered in the Natamycin Market report?

Ans: The Applications covered in the Natamycin Market report are Food, Medical, Others

What are the Type segmentation covered in the Natamycin Market report?

Ans: The Types covered in the Natamycin Market report are Glucose-based, Lactose-based, Sodium chloride-based

1 Study Coverage

1.1 Natamycin Product Introduction

1.2 Market by Type

1.2.1 Global Natamycin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Glucose-based

1.2.3 Lactose-based

1.2.4 Sodium chloride-based

1.3 Market by Application

1.3.1 Global Natamycin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Food

1.3.3 Medical

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Natamycin Sales Estimates and Forecasts 2019-2030

2.2 Global Natamycin Revenue by Region

2.2.1 Global Natamycin Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Natamycin Revenue by Region (2019-2024)

2.2.3 Global Natamycin Revenue by Region (2025-2030)

2.2.4 Global Natamycin Revenue Market Share by Region (2019-2030)

2.3 Global Natamycin Sales Estimates and Forecasts 2019-2030

2.4 Global Natamycin Sales by Region

2.4.1 Global Natamycin Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Natamycin Sales by Region (2019-2024)

2.4.3 Global Natamycin Sales by Region (2025-2030)

2.4.4 Global Natamycin Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Natamycin Sales by Manufacturers

3.1.1 Global Natamycin Sales by Manufacturers (2019-2024)

3.1.2 Global Natamycin Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Natamycin in 2023

3.2 Global Natamycin Revenue by Manufacturers

3.2.1 Global Natamycin Revenue by Manufacturers (2019-2024)

3.2.2 Global Natamycin Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Natamycin Revenue in 2023

3.3 Global Key Players of Natamycin, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Natamycin Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Natamycin, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Natamycin, Product Offered and Application

3.8 Global Key Manufacturers of Natamycin, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Natamycin Sales by Type

4.1.1 Global Natamycin Historical Sales by Type (2019-2024)

4.1.2 Global Natamycin Forecasted Sales by Type (2025-2030)

4.1.3 Global Natamycin Sales Market Share by Type (2019-2030)

4.2 Global Natamycin Revenue by Type

4.2.1 Global Natamycin Historical Revenue by Type (2019-2024)

4.2.2 Global Natamycin Forecasted Revenue by Type (2025-2030)

4.2.3 Global Natamycin Revenue Market Share by Type (2019-2030)

4.3 Global Natamycin Price by Type

4.3.1 Global Natamycin Price by Type (2019-2024)

4.3.2 Global Natamycin Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Natamycin Sales by Application

5.1.1 Global Natamycin Historical Sales by Application (2019-2024)

5.1.2 Global Natamycin Forecasted Sales by Application (2025-2030)

5.1.3 Global Natamycin Sales Market Share by Application (2019-2030)

5.2 Global Natamycin Revenue by Application

5.2.1 Global Natamycin Historical Revenue by Application (2019-2024)

5.2.2 Global Natamycin Forecasted Revenue by Application (2025-2030)

5.2.3 Global Natamycin Revenue Market Share by Application (2019-2030)

5.3 Global Natamycin Price by Application

5.3.1 Global Natamycin Price by Application (2019-2024)

5.3.2 Global Natamycin Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Natamycin Market Size by Type

6.1.1 US & Canada Natamycin Sales by Type (2019-2030)

6.1.2 US & Canada Natamycin Revenue by Type (2019-2030)

6.2 US & Canada Natamycin Market Size by Application

6.2.1 US & Canada Natamycin Sales by Application (2019-2030)

6.2.2 US & Canada Natamycin Revenue by Application (2019-2030)

6.3 US & Canada Natamycin Market Size by Country

6.3.1 US & Canada Natamycin Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Natamycin Sales by Country (2019-2030)

6.3.3 US & Canada Natamycin Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Natamycin Market Size by Type

7.1.1 Europe Natamycin Sales by Type (2019-2030)

7.1.2 Europe Natamycin Revenue by Type (2019-2030)

7.2 Europe Natamycin Market Size by Application

7.2.1 Europe Natamycin Sales by Application (2019-2030)

7.2.2 Europe Natamycin Revenue by Application (2019-2030)

7.3 Europe Natamycin Market Size by Country

7.3.1 Europe Natamycin Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Natamycin Sales by Country (2019-2030)

7.3.3 Europe Natamycin Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Natamycin Market Size

8.1.1 China Natamycin Sales (2019-2030)

8.1.2 China Natamycin Revenue (2019-2030)

8.2 China Natamycin Market Size by Application

8.2.1 China Natamycin Sales by Application (2019-2030)

8.2.2 China Natamycin Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Natamycin Market Size by Type

9.1.1 Asia Natamycin Sales by Type (2019-2030)

9.1.2 Asia Natamycin Revenue by Type (2019-2030)

9.2 Asia Natamycin Market Size by Application

9.2.1 Asia Natamycin Sales by Application (2019-2030)

9.2.2 Asia Natamycin Revenue by Application (2019-2030)

9.3 Asia Natamycin Sales by Region

9.3.1 Asia Natamycin Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Natamycin Revenue by Region (2019-2030)

9.3.3 Asia Natamycin Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Natamycin Market Size by Type

10.1.1 Middle East, Africa and Latin America Natamycin Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Natamycin Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Natamycin Market Size by Application

10.2.1 Middle East, Africa and Latin America Natamycin Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Natamycin Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Natamycin Sales by Country

10.3.1 Middle East, Africa and Latin America Natamycin Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Natamycin Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Natamycin Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Danisco

11.1.1 Danisco Company Information

11.1.2 Danisco Overview

11.1.3 Danisco Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Danisco Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Danisco Recent Developments

11.2 DSM

11.2.1 DSM Company Information

11.2.2 DSM Overview

11.2.3 DSM Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 DSM Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 DSM Recent Developments

11.3 VGP

11.3.1 VGP Company Information

11.3.2 VGP Overview

11.3.3 VGP Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 VGP Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 VGP Recent Developments

11.4 Handary

11.4.1 Handary Company Information

11.4.2 Handary Overview

11.4.3 Handary Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Handary Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Handary Recent Developments

11.5 AMTECH BIOTECH

11.5.1 AMTECH BIOTECH Company Information

11.5.2 AMTECH BIOTECH Overview

11.5.3 AMTECH BIOTECH Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 AMTECH BIOTECH Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 AMTECH BIOTECH Recent Developments

11.6 Silver-Elephant

11.6.1 Silver-Elephant Company Information

11.6.2 Silver-Elephant Overview

11.6.3 Silver-Elephant Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Silver-Elephant Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Silver-Elephant Recent Developments

11.7 Lanzhou Weiri

11.7.1 Lanzhou Weiri Company Information

11.7.2 Lanzhou Weiri Overview

11.7.3 Lanzhou Weiri Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Lanzhou Weiri Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Lanzhou Weiri Recent Developments

11.8 Langfang Meihua

11.8.1 Langfang Meihua Company Information

11.8.2 Langfang Meihua Overview

11.8.3 Langfang Meihua Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Langfang Meihua Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Langfang Meihua Recent Developments

11.9 Zhengzhou New Frey

11.9.1 Zhengzhou New Frey Company Information

11.9.2 Zhengzhou New Frey Overview

11.9.3 Zhengzhou New Frey Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Zhengzhou New Frey Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Zhengzhou New Frey Recent Developments

11.10 Chihon

11.10.1 Chihon Company Information

11.10.2 Chihon Overview

11.10.3 Chihon Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Chihon Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Chihon Recent Developments

11.11 Jiaozuo Joincare

11.11.1 Jiaozuo Joincare Company Information

11.11.2 Jiaozuo Joincare Overview

11.11.3 Jiaozuo Joincare Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Jiaozuo Joincare Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Jiaozuo Joincare Recent Developments

11.12 Beijing Oriental Rada

11.12.1 Beijing Oriental Rada Company Information

11.12.2 Beijing Oriental Rada Overview

11.12.3 Beijing Oriental Rada Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Beijing Oriental Rada Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Beijing Oriental Rada Recent Developments

11.13 Pucheng Lifecome

11.13.1 Pucheng Lifecome Company Information

11.13.2 Pucheng Lifecome Overview

11.13.3 Pucheng Lifecome Natamycin Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Pucheng Lifecome Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Pucheng Lifecome Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Natamycin Industry Chain Analysis

12.2 Natamycin Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Natamycin Production Mode & Process

12.4 Natamycin Sales and Marketing

12.4.1 Natamycin Sales Channels

12.4.2 Natamycin Distributors

12.5 Natamycin Customers

13 Market Dynamics

13.1 Natamycin Industry Trends

13.2 Natamycin Market Drivers

13.3 Natamycin Market Challenges

13.4 Natamycin Market Restraints

14 Key Findings in The Global Natamycin Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Beijing Oriental Rada

Pucheng Lifecome

List of Tables

Table 1. Global Natamycin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Glucose-based

Table 3. Major Manufacturers of Lactose-based

Table 4. Major Manufacturers of Sodium chloride-based

Table 5. Global Natamycin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Natamycin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Natamycin Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Natamycin Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Natamycin Revenue Market Share by Region (2019-2024)

Table 10. Global Natamycin Revenue Market Share by Region (2025-2030)

Table 11. Global Natamycin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Natamycin Sales by Region (2019-2024) & (MT)

Table 13. Global Natamycin Sales by Region (2025-2030) & (MT)

Table 14. Global Natamycin Sales Market Share by Region (2019-2024)

Table 15. Global Natamycin Sales Market Share by Region (2025-2030)

Table 16. Global Natamycin Sales by Manufacturers (2019-2024) & (MT)

Table 17. Global Natamycin Sales Share by Manufacturers (2019-2024)

Table 18. Global Natamycin Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Natamycin Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Natamycin, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Natamycin Price by Manufacturers 2019-2024 (USD/MT)

Table 22. Global Natamycin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Natamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2023)

Table 24. Global Key Manufacturers of Natamycin, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Natamycin, Product Offered and Application

Table 26. Global Key Manufacturers of Natamycin, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Natamycin Sales by Type (2019-2024) & (MT)

Table 29. Global Natamycin Sales by Type (2025-2030) & (MT)

Table 30. Global Natamycin Sales Share by Type (2019-2024)

Table 31. Global Natamycin Sales Share by Type (2025-2030)

Table 32. Global Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Natamycin Revenue Share by Type (2019-2024)

Table 35. Global Natamycin Revenue Share by Type (2025-2030)

Table 36. Natamycin Price by Type (2019-2024) & (USD/MT)

Table 37. Global Natamycin Price Forecast by Type (2025-2030) & (USD/MT)

Table 38. Global Natamycin Sales by Application (2019-2024) & (MT)

Table 39. Global Natamycin Sales by Application (2025-2030) & (MT)

Table 40. Global Natamycin Sales Share by Application (2019-2024)

Table 41. Global Natamycin Sales Share by Application (2025-2030)

Table 42. Global Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Natamycin Revenue Share by Application (2019-2024)

Table 45. Global Natamycin Revenue Share by Application (2025-2030)

Table 46. Natamycin Price by Application (2019-2024) & (USD/MT)

Table 47. Global Natamycin Price Forecast by Application (2025-2030) & (USD/MT)

Table 48. US & Canada Natamycin Sales by Type (2019-2024) & (MT)

Table 49. US & Canada Natamycin Sales by Type (2025-2030) & (MT)

Table 50. US & Canada Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Natamycin Sales by Application (2019-2024) & (MT)

Table 53. US & Canada Natamycin Sales by Application (2025-2030) & (MT)

Table 54. US & Canada Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Natamycin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Natamycin Sales by Country (2019-2024) & (MT)

Table 60. US & Canada Natamycin Sales by Country (2025-2030) & (MT)

Table 61. Europe Natamycin Sales by Type (2019-2024) & (MT)

Table 62. Europe Natamycin Sales by Type (2025-2030) & (MT)

Table 63. Europe Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Natamycin Sales by Application (2019-2024) & (MT)

Table 66. Europe Natamycin Sales by Application (2025-2030) & (MT)

Table 67. Europe Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Natamycin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Natamycin Sales by Country (2019-2024) & (MT)

Table 73. Europe Natamycin Sales by Country (2025-2030) & (MT)

Table 74. China Natamycin Sales by Type (2019-2024) & (MT)

Table 75. China Natamycin Sales by Type (2025-2030) & (MT)

Table 76. China Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Natamycin Sales by Application (2019-2024) & (MT)

Table 79. China Natamycin Sales by Application (2025-2030) & (MT)

Table 80. China Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Natamycin Sales by Type (2019-2024) & (MT)

Table 83. Asia Natamycin Sales by Type (2025-2030) & (MT)

Table 84. Asia Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Natamycin Sales by Application (2019-2024) & (MT)

Table 87. Asia Natamycin Sales by Application (2025-2030) & (MT)

Table 88. Asia Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Natamycin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Natamycin Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Natamycin Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Natamycin Sales by Region (2019-2024) & (MT)

Table 94. Asia Natamycin Sales by Region (2025-2030) & (MT)

Table 95. Middle East, Africa and Latin America Natamycin Sales by Type (2019-2024) & (MT)

Table 96. Middle East, Africa and Latin America Natamycin Sales by Type (2025-2030) & (MT)

Table 97. Middle East, Africa and Latin America Natamycin Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Natamycin Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Natamycin Sales by Application (2019-2024) & (MT)

Table 100. Middle East, Africa and Latin America Natamycin Sales by Application (2025-2030) & (MT)

Table 101. Middle East, Africa and Latin America Natamycin Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Natamycin Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Natamycin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Natamycin Sales by Country (2019-2024) & (MT)

Table 107. Middle East, Africa and Latin America Natamycin Sales by Country (2025-2030) & (MT)

Table 108. Danisco Company Information

Table 109. Danisco Description and Major Businesses

Table 110. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 111. Danisco Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Danisco Recent Developments

Table 113. DSM Company Information

Table 114. DSM Description and Major Businesses

Table 115. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 116. DSM Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. DSM Recent Developments

Table 118. VGP Company Information

Table 119. VGP Description and Major Businesses

Table 120. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 121. VGP Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. VGP Recent Developments

Table 123. Handary Company Information

Table 124. Handary Description and Major Businesses

Table 125. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 126. Handary Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Handary Recent Developments

Table 128. AMTECH BIOTECH Company Information

Table 129. AMTECH BIOTECH Description and Major Businesses

Table 130. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 131. AMTECH BIOTECH Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. AMTECH BIOTECH Recent Developments

Table 133. Silver-Elephant Company Information

Table 134. Silver-Elephant Description and Major Businesses

Table 135. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 136. Silver-Elephant Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Silver-Elephant Recent Developments

Table 138. Lanzhou Weiri Company Information

Table 139. Lanzhou Weiri Description and Major Businesses

Table 140. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 141. Lanzhou Weiri Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Lanzhou Weiri Recent Developments

Table 143. Langfang Meihua Company Information

Table 144. Langfang Meihua Description and Major Businesses

Table 145. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 146. Langfang Meihua Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Langfang Meihua Recent Developments

Table 148. Zhengzhou New Frey Company Information

Table 149. Zhengzhou New Frey Description and Major Businesses

Table 150. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 151. Zhengzhou New Frey Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Zhengzhou New Frey Recent Developments

Table 153. Chihon Company Information

Table 154. Chihon Description and Major Businesses

Table 155. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 156. Chihon Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Chihon Recent Developments

Table 158. Jiaozuo Joincare Company Information

Table 159. Jiaozuo Joincare Description and Major Businesses

Table 160. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 161. Jiaozuo Joincare Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Jiaozuo Joincare Recent Developments

Table 163. Beijing Oriental Rada Company Information

Table 164. Beijing Oriental Rada Description and Major Businesses

Table 165. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 166. Beijing Oriental Rada Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Beijing Oriental Rada Recent Developments

Table 168. Pucheng Lifecome Company Information

Table 169. Pucheng Lifecome Description and Major Businesses

Table 170. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 171. Pucheng Lifecome Natamycin Product Model Numbers, Pictures, Descriptions and Specifications

Table 172. Pucheng Lifecome Recent Developments

Table 173. Key Raw Materials Lists

Table 174. Raw Materials Key Suppliers Lists

Table 175. Natamycin Distributors List

Table 176. Natamycin Customers List

Table 177. Natamycin Market Trends

Table 178. Natamycin Market Drivers

Table 179. Natamycin Market Challenges

Table 180. Natamycin Market Restraints

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

List of Figures

Figure 1. Natamycin Product Picture

Figure 2. Global Natamycin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Natamycin Market Share by Type in 2023 & 2030

Figure 4. Glucose-based Product Picture

Figure 5. Lactose-based Product Picture

Figure 6. Sodium chloride-based Product Picture

Figure 7. Global Natamycin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Natamycin Market Share by Application in 2023 & 2030

Figure 9. Food

Figure 10. Medical

Figure 11. Others

Figure 12. Natamycin Report Years Considered

Figure 13. Global Natamycin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Natamycin Revenue 2019-2030 (US$ Million)

Figure 15. Global Natamycin Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Natamycin Revenue Market Share by Region (2019-2030)

Figure 17. Global Natamycin Sales 2019-2030 ((MT)

Figure 18. Global Natamycin Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Natamycin Sales YoY (2019-2030) & (MT)

Figure 20. US & Canada Natamycin Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Natamycin Sales YoY (2019-2030) & (MT)

Figure 22. Europe Natamycin Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Natamycin Sales YoY (2019-2030) & (MT)

Figure 24. China Natamycin Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Natamycin Sales YoY (2019-2030) & (MT)

Figure 26. Asia (excluding China) Natamycin Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Natamycin Sales YoY (2019-2030) & (MT)

Figure 28. Middle East, Africa and Latin America Natamycin Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Natamycin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Natamycin in the World: Market Share by Natamycin Revenue in 2023

Figure 31. Global Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Natamycin Sales Market Share by Type (2019-2030)

Figure 33. Global Natamycin Revenue Market Share by Type (2019-2030)

Figure 34. Global Natamycin Sales Market Share by Application (2019-2030)

Figure 35. Global Natamycin Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Natamycin Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Natamycin Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Natamycin Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Natamycin Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Natamycin Revenue Share by Country (2019-2030)

Figure 41. US & Canada Natamycin Sales Share by Country (2019-2030)

Figure 42. U.S. Natamycin Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Natamycin Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Natamycin Sales Market Share by Type (2019-2030)

Figure 45. Europe Natamycin Revenue Market Share by Type (2019-2030)

Figure 46. Europe Natamycin Sales Market Share by Application (2019-2030)

Figure 47. Europe Natamycin Revenue Market Share by Application (2019-2030)

Figure 48. Europe Natamycin Revenue Share by Country (2019-2030)

Figure 49. Europe Natamycin Sales Share by Country (2019-2030)

Figure 50. Germany Natamycin Revenue (2019-2030) & (US$ Million)

Figure 51. France Natamycin Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Natamycin Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Natamycin Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Natamycin Revenue (2019-2030) & (US$ Million)

Figure 55. China Natamycin Sales Market Share by Type (2019-2030)

Figure 56. China Natamycin Revenue Market Share by Type (2019-2030)

Figure 57. China Natamycin Sales Market Share by Application (2019-2030)

Figure 58. China Natamycin Revenue Market Share by Application (2019-2030)

Figure 59. Asia Natamycin Sales Market Share by Type (2019-2030)

Figure 60. Asia Natamycin Revenue Market Share by Type (2019-2030)

Figure 61. Asia Natamycin Sales Market Share by Application (2019-2030)

Figure 62. Asia Natamycin Revenue Market Share by Application (2019-2030)

Figure 63. Asia Natamycin Revenue Share by Region (2019-2030)

Figure 64. Asia Natamycin Sales Share by Region (2019-2030)

Figure 65. Japan Natamycin Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Natamycin Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Natamycin Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Natamycin Revenue (2019-2030) & (US$ Million)

Figure 69. India Natamycin Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Natamycin Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Natamycin Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Natamycin Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Natamycin Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Natamycin Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Natamycin Sales Share by Country (2019-2030)

Figure 76. Brazil Natamycin Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Natamycin Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Natamycin Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Natamycin Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Natamycin Revenue (2019-2030) & (US$ Million)

Figure 81. Natamycin Value Chain

Figure 82. Natamycin Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions